SILVERBACK THERAPEUTICS
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways. They developing a new generation of systemically delivered, locally active therapies that potently modulate fundamental disease pathways once deemed inaccessible. Silverback Therapeutics is building a platform technology capable of unlocking potent immuno-modulatory pathways using an established antibody-guided approach for targeting disease sites. The company's proprietary ImmunoTAC technology and integrated R&D approach enables the design of product candidates that can be administered systemically, but that act only at the sites of disease.
SILVERBACK THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.silverbacktx.com
Total Employee:
11+
Status:
Active
Contact:
(206) 456-2900
Email Addresses:
[email protected]
Total Funding:
221 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Kinnate Biopharma
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
ProJenX
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vivace Therapeutics
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
EcoR1 Capital
EcoR1 Capital investment in Series C - Silverback Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Silverback Therapeutics
OrbiMed
OrbiMed investment in Series C - Silverback Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Silverback Therapeutics
Nextech Invest
Nextech Invest investment in Series C - Silverback Therapeutics
Pontifax
Pontifax investment in Series C - Silverback Therapeutics
Hunt Technology Ventures
Hunt Technology Ventures investment in Series C - Silverback Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Silverback Therapeutics
U.S. Venture Partners
U.S. Venture Partners investment in Series C - Silverback Therapeutics
Nantahala Capital Management
Nantahala Capital Management investment in Series C - Silverback Therapeutics
Official Site Inspections
http://www.silverbacktx.com Semrush global rank: 3.3 M Semrush visits lastest month: 4.92 K
- Host name: 104.21.25.158
- IP address: 104.21.25.158
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago